Advanced Wound Care Dressings Segment to Dominate North America Diabetic Foot Ulcer Treatment Market During 2021–2028  

According to a new market research study on “North America Diabetic Foot Ulcer Treatment Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Ulcer Type, and End User” is expected to reach US$ 3,428.51 million by 2028 from US$ 1,978.20 million in 2021. The market is estimated to grow at a CAGR of 8.2% from 2021 to 2028. The report provides trends prevailing in the North America diabetic foot ulcer treatment market along with the drivers and restraints pertaining to the market growth. Rising prevalence of diabetes and related chronic wounds and increase in the geriatric population are the major factor driving the growth of the North America diabetic foot ulcer treatment market. However, overpriced advanced wound care treatments hinders the growth of North America diabetic foot ulcer treatment market.

In case of COVID-19, North America is highly affected specially the US. North America has been witnessing a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases increased to 33,321,244, with 593,148 deaths reported in the US as of May 06, 2021. The number of cases is also growing in Mexico and Canada. In Mexico, the cases have reached 2,355,985, with 218,007 deaths. The pandemic is straining public health systems globally, interrupting and delaying many kinds of critical health care. A recent survey by the World Health Organization found that health services are among the most frequently disrupted. 7 in 10 countries around the world are experiencing disruptions along with United states, Canada, and Mexico. However, as vaccines become available in 2021 the demand for wound care products is expected to increase. As treatment of chronic wounds like diabetic foot ulcer is essential for patients to ensure it is on the correct trajectory to heal, generally clinicians treat chronic wounds at least once a week to assess the progress of the wound. The American Medical Association has recommended to establish hospital-based outpatient wound center and home-based treatment options to manage and treat chronic wounds like diabetic foot ulcers. This is expected to increase the demand for treatment products that can be used at home as well as at outpatient centers. This is likely to favor the growth of diabetic foot ulcer treatment products.

The North America diabetic foot ulcer treatment market is segmented based on the type, ulcer type, end user, and country. Based on type, the market has been segmented into the advanced wound care dressings, biologics, and therapy device. The advanced wound care dressings segment dominated the North America diabetic foot ulcer treatment market in 2020 and biologics segment is expected to be fastest growing during forecast. Further, advanced wound care dressings is segmented into hydrogel dressings, collagen dressing, alginate dressings, foam dressings, hydrocolloid dressings, and others. Further, biologics is segmented into the skin grafts and growth factors. Similarly, therapy device is segmented into negative pressure wound therapy and ultrasound therapy. Based on ulcer type, the market has been segmented into neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers. The neuro-ischemic ulcers segment dominated the North America diabetic foot ulcer treatment market in 2020 and same segment is expected to be fastest growing during forecast. Moreover, based on end user, the market has been segmented into the hospitals, ambulatory surgery centers, and home care. The hospital segment dominated the North America diabetic foot ulcer treatment market in 2020 and same segment is expected to be fastest growing during forecast. Based on country, the market has been segmented into the US, Canada, and Mexico. 

3M; B. Braun Melsungen AG; Cardinal Health Inc; Coloplast Group; ConvaTec Group Plc; Kerecis; Medline Industries, Inc.; MiMedx; Mölnlycke Health Care AB.; Organogenesis Inc.; Smith & Nephew; and URGO are among the leading companies in the North America diabetic foot ulcer treatment market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, ConvaTec Group Plc has launched ConvaMax the new superabsorber dressing. ConvaMax superabsorber wound dressing is used for the management of highly exuding wounds, including leg ulcers, pressure ulcers, diabetic foot ulcers and dehisced surgical wounds.    

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com